Zürcher Nachrichten - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.135358
AFN 74.30766
ALL 92.174985
AMD 408.089217
ANG 2.015714
AOA 1033.546642
ARS 1716.797186
AUD 1.619592
AWG 2.029376
AZN 1.918444
BAM 1.95959
BBD 2.267215
BDT 138.392725
BGN 1.895331
BHD 0.424498
BIF 3374.787384
BMD 1.125867
BND 1.440686
BOB 13.524675
BRL 5.876469
BSD 1.125692
BTN 109.052025
BWP 15.561542
BYN 3.390557
BYR 22067.000075
BZD 2.263878
CAD 1.604846
CDF 2600.753988
CHF 0.932922
CLF 0.028273
CLP 1116.41447
CNY 7.548434
CNH 7.550574
COP 3685.008874
CRC 515.797517
CUC 1.125867
CUP 27.015606
CVE 110.729497
CZK 24.452605
DJF 200.089588
DKK 7.475427
DOP 67.210877
DZD 150.457842
EGP 58.890973
ERN 16.88801
ETB 183.858169
FJD 2.530106
FKP 0.853334
GBP 0.850312
GEL 2.921671
GGP 0.853334
GHS 13.220097
GIP 0.853334
GMD 82.755586
GNF 9901.797609
GTQ 8.602331
GYD 235.465374
HKD 8.834968
HNL 30.22185
HRK 7.537124
HTG 147.405071
HUF 368.853851
IDR 20182.29813
ILS 3.436519
IMP 0.853334
INR 108.275395
IQD 1474.671561
IRR 1966371.237333
ISK 137.232406
JEP 0.853334
JMD 178.204636
JOD 0.798284
JPY 177.641044
KES 146.081722
KGS 98.457532
KHR 4565.830004
KMF 493.130294
KPW 1013.280974
KRW 1515.158936
KWD 0.347702
KYD 0.938014
KZT 505.758102
LAK 25284.899273
LBP 100798.556354
LKR 372.246674
LRD 192.482248
LSL 18.820629
LTL 3.324394
LVL 0.681026
LYD 7.208942
MAD 11.183927
MDL 20.115903
MGA 4973.61864
MKD 61.700146
MMK 2364.184695
MNT 4051.28469
MOP 9.098496
MRU 44.980391
MUR 54.210939
MVR 17.395076
MWK 1951.874793
MXN 20.487452
MYR 4.599398
MZN 71.954607
NAD 18.82155
NGN 1495.895338
NIO 41.418629
NOK 10.829363
NPR 174.48324
NZD 2.006161
OMR 0.432897
PAB 1.125677
PEN 3.900705
PGK 5.097995
PHP 70.532779
PKR 311.766358
PLN 4.38518
PYG 6585.824279
QAR 4.10319
RON 5.343821
RSD 117.455029
RUB 94.346891
RWF 1667.124104
SAR 4.229236
SBD 9.079953
SCR 15.495772
SDG 677.21335
SEK 11.294143
SGD 1.440334
SHP 0.852801
SLE 27.700465
SLL 23608.866271
SOS 643.321284
SRD 42.570738
STD 23303.181044
STN 24.547801
SVC 9.849179
SYP 14638.527581
SZL 18.816722
THB 37.811172
TJS 10.361639
TMT 3.951794
TND 3.354332
TOP 2.710818
TRY 55.325013
TTD 7.632761
TWD 35.848785
TZS 2966.663889
UAH 50.651406
UGX 4491.746576
USD 1.125867
UYU 45.368949
UZS 13277.030654
VES 974.413465
VND 29256.226043
VUV 135.199002
WST 3.130892
XAF 655.957
XAG 0.01869
XAU 0.000272045889
XCD 3.042713
XCG 2.028723
XDR 0.796047
XOF 655.957
XPF 119.331742
YER 266.126937
ZAR 18.759556
ZMK 10134.161233
ZMW 22.118776
ZWL 362.528828
SSP 6431.620713
MXV 2.318114
  • BCC

    0.5100

    75.21

    +0.68%

  • RYCEF

    0.3000

    19.7

    +1.52%

  • RBGPF

    0.0000

    65

    0%

  • GSK

    -0.1000

    47.08

    -0.21%

  • CMSC

    0.1100

    20.27

    +0.54%

  • NGG

    0.9650

    76.295

    +1.26%

  • BTI

    0.2499

    52.605

    +0.48%

  • RIO

    1.1600

    94.03

    +1.23%

  • AZN

    -0.5500

    157.15

    -0.35%

  • BCE

    -0.1000

    19.82

    -0.5%

  • JRI

    0.0500

    10.82

    +0.46%

  • VOD

    0.4400

    16.82

    +2.62%

  • CMSD

    0.0600

    20.4

    +0.29%

  • RELX

    -0.1300

    33.36

    -0.39%

  • BP

    0.3350

    44.835

    +0.75%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

F.Schneider--NZN